Our Press Releases
Article Category
Gastrointestinal stromal tumors (GISTs)
Tyrosine Kinase Inhibitors Used in Gastrointestinal stromal tumors (GISTs) Introduction A gastrointestinal stromal tumor
Role of Direct Factor Xa inhibitors in Cardiovascular Events
Introduction Direct Factor Xa inhibitors are a type of anticoagulant drugs which act by binding selectively
Benefits of Direct Factor Xa inhibitors over Warfarin
Benefits of Direct Factor Xa inhibitors over Warfarin Introduction Compared to vitamin K antagonists
JAK inhibitors As a New Therapeutic Option
Introduction The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway; involved
Tofacitinib the first FDA approved JAK inhibitor
An overview of Tofacitinib, the first FDA approved JAK inhibitor, and its Indications Introduction Tofacitinib
increase Risk of Developing Diabetes
COVID-19 infection even mild ones may increase Risk of Developing Diabetes A recent
Benefits of lenalidomide in hematological malignancies
Abstract Lenalidomide is an immunomodulatory drug, which has effect against most of the hematological
Melonama Monday, May Is Melanoma
Melonama Monday, May Is Melanoma Awareness Month It is Good to Know about
Waldenstrom Macroglobulinemia (WM)
Introduction of Waldenstrom Macroglobulinemia (WM) Waldenstrom Macroglobulinemia (WM) is a non-Hodgkin lymphoma (NHL),